[{"Assets_0_Q1_USD":"749369000.0","CIK":"1737287","CommonStockSharesConverted_0_Q1_shares":"121527320.0","CommonStockSharesOutstanding_0_Q1_shares":"121527320.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.32","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-30256000.0","NetIncomeLoss_1_Q1_USD":"-31586000.0","NetIncomeLoss_5_Q1_USD":"-243100000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_1_Q1_USD":"-31586000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"681228000.0","Ticker":"ALLO","filed":"20190507","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20190331","qtrs":"0","uom":"USD"}]